Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects

Journal of Psychopharmacology
Liesbeth RenemanGerard J. Den Heeten

Abstract

Users of ecstasy (3,4-methylenedioxymethamphetamine; MDMA) may be at risk of developing MDMA-induced injury to the serotonin (5-HT) system. Previously, there were no methods available for directly evaluating the neurotoxic effects of MDMA in the living human brain. However, development of in vivoneuroimaging tools have begun to provide insights into the effects of ecstasy on the human brain. Single photon emission computed tomography (SPECT), positron emission computed tomography (PET) and proton magnetic resonance spectroscopy (1H-MRS) studies which have evaluated ecstasy's neurotoxic potential will be reviewed and discussed in terms of technical aspects, conceptual issues and future prospects. Although PET and SPECT may be limited by several factors such as the low cortical uptake and the use of a non-optimal reference region (cerebellum) the few studies conducted so far provide suggestive evidence that people who heavily use ecstasy are at risk of developing subcortical, and probably also cortical reductions in serotonin transporter (SERT) densities, a marker of 5-HT neurotoxicity. There seem to be dose-dependent and transient reductions in SERT for which females may be more vulnerable than males. 1H-MRS appears to be a less...Continue Reading

References

Nov 1, 1992·Neuroreport·J W BojaM J Kuhar
Jan 1, 1990·Annals of the New York Academy of Sciences·G A RicaurteJ W Langston
Jan 1, 1990·Annals of the New York Academy of Sciences·M E MolliverM A Wilson
Feb 26, 1991·European Journal of Pharmacology·J W BojaM J Kuhar
Jul 1, 1988·JAMA : the Journal of the American Medical Association·G A RicaurteJ W Langston
May 31, 1985·Science·D F Swaab, E Fliers
Apr 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·U D McCannG A Ricaurte
Apr 1, 1995·European Journal of Nuclear Medicine·J T KuikkaP Hakola
Jan 1, 1997·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·I StraussE J Fernandez
Apr 27, 1999·Lancet·J T Kuikka, A K Ahonen
Sep 11, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·H J GijsmanA F Cohen
Oct 3, 1999·Journal of Magnetic Resonance Imaging : JMRI·L ChangR E Poland
Jan 6, 2000·The British Journal of Psychiatry : the Journal of Mental Science·D M SempleE C Johnstone
Feb 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·A Heinz, D W Jones
Feb 24, 2001·Psychopharmacology·R J VerkesA F Cohen
Mar 21, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·U D McCann, G A Ricaurte
Apr 21, 2001·Psychopharmacology·M E LiechtiF X Vollenweider
Nov 8, 2001·European Archives of Psychiatry and Clinical Neuroscience·T ObergriesserF A Henn
Dec 14, 2001·Lancet·G A Ricaurte, U D McCann
Apr 5, 2002·Nature·Steve Fuller
Jul 10, 2002·Annals of the New York Academy of Sciences·Jerrold S Meyer, Syed F Ali
Oct 26, 2002·European Journal of Pharmacology·Brendon P BootGeorge A Ricaurte
Nov 20, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Yiyun HuangMarc Laruelle
Mar 25, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·William E FantegrossiGail Winger

❮ Previous
Next ❯

Citations

Jul 19, 2006·Psychopharmacology·Ronald L Cowan
Nov 9, 2007·Psychological Medicine·T SchiltW van den Brink
Dec 17, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yen F TaiPaola Piccini
Apr 27, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gerry JagerNick F Ramsey
Oct 10, 2008·Brain : a Journal of Neurology·Maartje M L de WinWim van den Brink
Oct 22, 2013·Psychopharmacology·Simon N YoungChawki Benkelfat
Oct 14, 2009·Psychopharmacology·Thelma SchiltBen Schmand
Nov 21, 2008·Psychopharmacology·Thelma SchiltBen Schmand
Oct 2, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Maartje M L de WinWim van den Brink
Apr 2, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Sudhakar SelvarajPaul Grasby
Oct 7, 2009·Addiction·Neeltje VogelsRaymond J M Niesink
Aug 26, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Li WanMatthew S Stanford
Dec 2, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Thelma SchiltWim van den Brink
Nov 7, 2007·Neuroimaging Clinics of North America·Diana MartinezAnissa Abi-Dargham
Oct 2, 2007·Neurochemistry International·Sushil Sharma, Manuchair Ebadi
Nov 18, 2006·Neuroscience and Biobehavioral Reviews·Kelly Allott, Jennifer Redman
Jul 16, 2011·Pharmacology, Biochemistry, and Behavior·Wael M Y MohamedByron C Jones
May 11, 2013·Neuroscience and Biobehavioral Reviews·Andrew C Parrott
Dec 21, 2012·Journal of Psychopharmacology·Ac ParrottJ Thome
Mar 3, 2006·Journal of Psychopharmacology·Andy C Parrott, Charles A Marsden
Jun 3, 2008·Journal of Psychopharmacology·J E Fisk, C Montgomery
Jan 11, 2007·Journal of Psychopharmacology·A C Parrott
Nov 2, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Maartje M L de WinWim van den Brink
Mar 3, 2006·Journal of Psychopharmacology·Maartje M L de WinWim van den Brink
Aug 18, 2006·Human Psychopharmacology·John E FiskPhilip N Murphy
Mar 9, 2007·Depression and Anxiety·Heather DurdleManuel Tancer
Oct 22, 2010·International Journal of Offender Therapy and Comparative Criminology·Allan Borowski
Jun 30, 2019·Pharmacological Reviews·Madeline M Pantoni, Stephan G Anagnostaras
May 8, 2018·Journal of Psychopharmacology·Balázs SzigetiLarissa J Maier

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.